Interestingly, PSMA-low prostate tumors with neuroendocrine features have been suggested to express high levels of glucose transporters and hexokinases, and due to increased uptake of glucose, 18F-FDG-PET could be an efficient imaging method for these prostate cancers [129,130,131,132]. This evidence concerns the gene FOLH1 and prostate cancer.